Liver Cirrhosis Recruiting Phase 3 Trials for Rifaximin (DB01220)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03069131Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With AscitesTreatment
NCT02120196Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial PeritonitisPrevention
NCT02508623Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal VaricesTreatment